These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21172869)

  • 21. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
    Lin JS; Park S; Adamovicz JJ; Hill J; Bliska JB; Cote CK; Perlin DS; Amemiya K; Smiley ST
    Vaccine; 2010 Dec; 29(2):357-62. PubMed ID: 20840834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.
    Ali R; Naqvi RA; Kumar S; Bhat AA; Rao DN
    Scand J Immunol; 2013 May; 77(5):361-71. PubMed ID: 23480362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
    Sha J; Kirtley ML; Klages C; Erova TE; Telepnev M; Ponnusamy D; Fitts EC; Baze WB; Sivasubramani SK; Lawrence WS; Patrikeev I; Peel JE; Andersson JA; Kozlova EV; Tiner BL; Peterson JW; McWilliams D; Patel S; Rothe E; Motin VL; Chopra AK
    Clin Vaccine Immunol; 2016 Jul; 23(7):586-600. PubMed ID: 27170642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.
    Sun W; Roland KL; Kuang X; Branger CG; Curtiss R
    Infect Immun; 2010 Mar; 78(3):1304-13. PubMed ID: 20086087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yersinia pestis V protein epitopes recognized by CD4 T cells.
    Parent MA; Berggren KN; Mullarky IK; Szaba FM; Kummer LW; Adamovicz JJ; Smiley ST
    Infect Immun; 2005 Apr; 73(4):2197-204. PubMed ID: 15784563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.
    Yamanaka H; Hoyt T; Yang X; Golden S; Bosio CM; Crist K; Becker T; Maddaloni M; Pascual DW
    Infect Immun; 2008 Oct; 76(10):4564-73. PubMed ID: 18694965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
    Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection.
    Okan NA; Mena P; Benach JL; Bliska JB; Karzai AW
    Infect Immun; 2010 Mar; 78(3):1284-93. PubMed ID: 20065026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
    Branger CG; Fetherston JD; Perry RD; Curtiss R
    Adv Exp Med Biol; 2007; 603():387-99. PubMed ID: 17966435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated defense against Yersinia pestis infection.
    Smiley ST
    Adv Exp Med Biol; 2007; 603():376-86. PubMed ID: 17966434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.
    Branger CG; Sun W; Torres-Escobar A; Perry R; Roland KL; Fetherston J; Curtiss R
    Vaccine; 2010 Dec; 29(2):274-82. PubMed ID: 20979987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.
    Grosfeld H; Cohen S; Bino T; Flashner Y; Ber R; Mamroud E; Kronman C; Shafferman A; Velan B
    Infect Immun; 2003 Jan; 71(1):374-83. PubMed ID: 12496187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
    Honko AN; Sriranganathan N; Lees CJ; Mizel SB
    Infect Immun; 2006 Feb; 74(2):1113-20. PubMed ID: 16428759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.
    Zhang Q; Wang Q; Tian G; Qi Z; Zhang X; Wu X; Qiu Y; Bi Y; Yang X; Xin Y; He J; Zhou J; Zeng L; Yang R; Wang X
    Hum Vaccin Immunother; 2014; 10(2):368-77. PubMed ID: 24225642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection Induced by Oral Vaccination with a Recombinant
    Majumder S; Olson RM; Singh A; Wang X; Li P; Kittana H; Anderson PE; Anderson DM; Sun W
    Infect Immun; 2022 Aug; 90(8):e0016522. PubMed ID: 35900096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yersinia pestis YadC: a novel vaccine candidate against plague.
    Murphy BS; Wulff CR; Garvy BA; Straley SC
    Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.
    DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O
    Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.